Welcome to the Joint ASCEPT-APSA 2012 Conference

On behalf of the Joint Program Committee, ASCEPT and APSA invite you to attend the Joint ASCEPT-APSA Scientific Conference to be held in Sydney from 2 to 5 December 2012. This conference is the major gathering of academics and researchers in the fields of clinical and experimental pharmacology, pharmacy practice and pharmaceutical sciences, clinical and experimental toxicology across Australia and New Zealand. The theme for this year’s conference is Medication Safety.

We believe this important collaborative conference will be an excellent opportunity to showcase the world class research undertaken by ASCEPT and APSA members. Importantly, this conference offers the opportunity to network with colleagues and other leading international and national scientists and academics at both social and scientific activities. A key feature of the meeting is the chance for early career researchers and research students to present their research findings in poster and oral presentations sessions. Annual awards and prizes from both ASCEPT and APSA will also be presented at this meeting.

The program of plenary lectures, symposia and workshops, oral presentations and posters will be scientifically stimulating and lead to new collaborations and research opportunities.

Our international guests include Dr Yoon Loke from the British Pharmacological Society.

We look forward to welcoming you to Sydney.

Prof Carl Kirkpatrick Co-Chair, Joint Program Committee	Prof Andrew McLachlan Co-Chair, Joint Program Committee and APSA President	Prof David Le Couteur ASCEPT President

Who should attend:
• Academic and industrial scientists associated with discovery, formulation and the delivery of drugs
• Clinicians involved in the prescription and/or review of therapeutic agents
• Regulatory and clinical scientists involved in drug development and drug registration
• Researchers in clinical pharmacy, pharmacology and toxicology
• Education providers in pharmacy, pharmacology and toxicology
• Students and postdoctoral fellows from Australia and New Zealand in all areas of the pharmaceutical sciences
• Government agencies involved in chemical safety assessment and registration
• Medical practitioners such as clinical pharmacologists, clinical toxicologists, cardiologists and general physicians

Key Dates